Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pulse Biosciences CS (NQ: PLSE ) 19.87 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pulse Biosciences CS Pulse Biosciences Announces Its Novel Nanosecond Pulsed Field Ablation System Will Be Highlighted at the 2023 AF Symposium February 02, 2023 From Pulse Biosciences Via Business Wire 12 Health Care Stocks Moving In Tuesday's Intraday Session December 06, 2022 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session December 02, 2022 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session November 25, 2022 Via Benzinga Pulse Biosciences Lead Therapeutic System Scores FDA Approval For Sebaceous Hyperplasia September 26, 2022 Via Benzinga Pulse Biosciences Shifts Core Technology Focus, Reduces Dermatologic Footprint September 21, 2022 Via Benzinga Recap: Pulse Biosciences Q2 Earnings August 10, 2022 Pulse Biosciences (NASDAQ:PLSE) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session November 24, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session November 23, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session November 22, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session November 15, 2022 Via Benzinga Pulse Biosciences Reports Third Quarter 2022 Financial Results November 10, 2022 From Pulse Biosciences, Inc. Via Business Wire Earnings Preview: Pulse Biosciences November 09, 2022 Pulse Biosciences (NASDAQ:PLSE) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that Pulse... Via Benzinga Pulse Biosciences Schedules Third Quarter 2022 Financial Results Conference Call for November 10, 2022 October 27, 2022 From Pulse Biosciences, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's After-Market Session October 20, 2022 Gainers Nuwellis (NASDAQ:NUWE) stock rose 13.9% to $0.28 during Thursday's after-market session. The company's market cap stands at $8.9 million. Via Benzinga Pulse Biosciences Announces Positive Clinical Data on Nano-Pulse Stimulation Procedure for Low-Risk Basal Cell Carcinoma Lesions October 06, 2022 From Pulse Biosciences, Inc. Via Business Wire Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session October 04, 2022 Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session September 26, 2022 Gainers Via Benzinga Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday October 03, 2022 Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37. Via Benzinga Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday September 27, 2022 Gainers Via Benzinga Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia September 26, 2022 From Pulse Biosciences, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022 September 21, 2022 Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago... Via Benzinga Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation September 20, 2022 From Pulse Biosciences, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's After-Market Session August 24, 2022 Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 20.1% to $1.79 during Wednesday's after-market session. The market value of their outstanding shares is at $31.6 million. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session August 10, 2022 Via Benzinga Pulse Biosciences Reports Second Quarter 2022 Financial Results August 10, 2022 From Pulse Biosciences, Inc. Via Business Wire A Preview Of Pulse Biosciences Earnings August 09, 2022 Pulse Biosciences (NASDAQ:PLSE) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Via Benzinga Recap Of Thursday's Biotech Catalysts - End Of the Day Summary August 04, 2022 The European Commission (EC) has approved AstraZeneca (NASDAQ: AZN) and Merck’s (NYSE: MRK) LYNPARZA as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients... Via Benzinga Pulse Biosciences Receives FDA 510(k) Clearance of Expanded Energy Settings for use with the CellFX® System August 04, 2022 From Pulse Biosciences, Inc. Via Business Wire Pulse Biosciences Schedules Second Quarter 2022 Financial Results Conference Call for August 10, 2022 July 27, 2022 From Pulse Biosciences, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
